BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15699818)

  • 1. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
    Corso M; Ravindranath TM
    Pediatr Emerg Care; 2005 Feb; 21(2):99-101. PubMed ID: 15699818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
    Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
    Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
    Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
    J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
    Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-induced immune hemolytic anemia.
    Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
    Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic anemia from ceftriaxone in an elderly patient: a case report.
    Imam SN; Wright K; Bhoopalam N; Choudhury A
    J Am Med Dir Assoc; 2008 Oct; 9(8):610-1. PubMed ID: 19083297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection.
    Quillen K; Lane C; Hu E; Pelton S; Bateman S
    Pediatr Infect Dis J; 2008 Apr; 27(4):357-8. PubMed ID: 18316983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
    Northrop MS; Agarwal HS
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.
    Borgna-Pignatti C; Bezzi TM; Reverberi R
    Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of acute hemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry.
    Kakaiya R; Cseri J; Smith S; Silberman S; Rubinas TC; Hoffstadter A
    Arch Pathol Lab Med; 2004 Aug; 128(8):905-7. PubMed ID: 15270609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
    Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
    Perm J; 2020; 24():. PubMed ID: 31905339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis.
    Liu W; Yu D
    Pediatr Allergy Immunol; 2014 Feb; 25(1):101-2. PubMed ID: 24118095
    [No Abstract]   [Full Text] [Related]  

  • 15. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
    Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
    Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness.
    Tasch J; Gonzalez-Zayaz P
    Am J Case Rep; 2017 Apr; 18():431-435. PubMed ID: 28428532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion med illustrated: Ceftriaxone-induced acute hemolytic anemia.
    Tobian AA; Shirey RS; Savage WJ
    Transfusion; 2010 Aug; 50(8):1647-8. PubMed ID: 20931689
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant.
    Wang Y; Pan T; Ma FR; Wang JJ; Zhang K; Pan WW; Zhang JH; Yi ZM; Ying YQ
    Chin Med J (Engl); 2019 Jan; 132(1):100-102. PubMed ID: 30628967
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe hemolytic crisis after ceftriaxone administration.
    Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
    Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.